China on the Move: Lesson from China's National Negotiation of Drug Prices in 2021 | Insights
In December 2021, China’s National Healthcare Security Administration (NHSA) published the 2021 National Reimbursement Drug List (2021 NRDL), implementing greater pricing discounts than those seen in 2020.